📰 Forward Looking Statements News
Page 57 - Forward Looking Statements News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Forward Looking Statements. Real-time updates on events, politics, business and more.
February 16, 2024
Approval based on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth approved indication for Dupixent in Japan and the sixth indication for...
February 16, 2024
Approval based on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth approved indication for...
February 16, 2024
Company further establishes itself as the dominant consumer finance platform in Southeast AsiaSINGAPORE, Feb. 16, 2024 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY) (“MoneyHero” or the “Company”), a market-leading personal finance aggregation and comparison platform in Greater Southeast Asia, today reported that, based on a preliminary and unaudited review, the Company anticipates year-over-year revenue growth of at least 60% in Singapore and 50% in Hong Kong fo...
February 16, 2024
Arch Capital Group Ltd. (NASDAQ:ACGL) Q4 2023 Earnings Call Transcript February 15, 2024 Arch Capital Group Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, ladies and gentlemen, and welcome to the Q4 2023 Arch Capital Earnings Conference […]
February 16, 2024
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and pharmaceutical products, proudly announced the administration of the first dose of FOLOTYN® (Pralatrexate Injection) to a patient in China. This remarks a pivotal step in CASI's commitment to addressing critical medical needs in peripheral T-cell lymphoma in China market.
February 16, 2024
No Impact on Cash, Cash Equivalents and Marketable Investments, Cash Runway or Business OperationsCompany Targeting On or Before March 14, 2024 to File Amended Financial Statements and Report Fourth...
February 16, 2024
Federal National Mortgage Association (PNK:FNMA) Q4 2023 Earnings Call Transcript February 15, 2024 Federal National Mortgage Association isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome to the Fannie Mae Fourth Quarter and Full-Year 2023 Financial Results […]
February 16, 2024
Treasure Global Inc. (NASDAQ:TGL) Q2 2024 Earnings Call Transcript February 15, 2024 Treasure Global Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone, and welcome to Treasure Global Inc.’s Second Quarter of Fiscal Year 2024 Conference Call. […]
February 16, 2024
NETSTREIT Corp. (NYSE:NTST) Q4 2023 Earnings Call Transcript February 15, 2024 NETSTREIT Corp. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the NETSTREIT’s Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference […]
February 16, 2024
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript February 15, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.28, expectations were $0.25. Corcept Therapeutics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Corcept […]